scispace - formally typeset
N

Nima Fattahi

Researcher at Tehran University of Medical Sciences

Publications -  36
Citations -  443

Nima Fattahi is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 6, co-authored 27 publications receiving 109 citations. Previous affiliations of Nima Fattahi include Kurdistan University of Medical Sciences.

Papers
More filters
Journal ArticleDOI

Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Rajesh Sharma, +403 more
TL;DR: The increase in incidence rates in people younger than 50 years and the fast-rising burden in low SDI and middle SDI countries in Asia and Africa calls for colorectal cancer prevention approaches, greater awareness, and cost-effective screening and therapeutic options in these regions.
Journal ArticleDOI

Non-communicable diseases' risk factors in Iran; a review of the present status and action plans

TL;DR: In this article, the most critical risk factors in Iran and the implemented programs and action plans to control them are discussed and a better knowledge on current status of risk factors and plans to tackle them, could help policymakers effectively rule policies and allocate resources to curb heavy burden of NCDs in Iran.
Journal ArticleDOI

Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?

TL;DR: Pentoxifylline's main functions, better circulation‐oxygenation properties, low price and safety, make it a promising drug to be considered for COVID‐19 treatment, especially as an adjuvant therapy in combination with other drugs.
Journal ArticleDOI

Epidemiologic pattern of cancers in Iran; current knowledge and future perspective.

TL;DR: Overall epidemiologic pattern of cancers and their burden transition is reviewed and more concerning neoplasia (gastrointestinal, breast, thyroid, urologic, and respiratory system cancers) are reviewed in more details.